Advertisement
Organisation › Details
AbCellera Biologics Inc.
AbCellera is a privately held company that engages in partnerships to discover and develop next-generation therapeutic antibodies. AbCellera’s single-cell platform integrates end-to-end capabilities for therapeutic antibody discovery through a combination of technologies including proprietary immunizations, microfluidics, high-throughput imaging, genomics, computation, and laboratory automation. Ultra-deep screening of single B cells allows unprecedented access to natural immune responses, enabling rapid isolation of large and diverse panels of high-quality lead antibodies from any species, including humans. *
Start | 2012-01-01 established | |
Group | AbCellera (Group) | |
Predecessor | University of British Columbia (UBC) | |
Industry | MAb | |
Industry 2 | single cell analysis | |
Person | Hansen, Carl (AbCellera 201902 CEO) | |
Region | Vancouver, BC | |
Country | Canada | |
Street | 2215 Yukon Street | |
City | V5Y 0A1 Vancouver, BC | |
Tel | +1-604-559-9005 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | B: 11 to 50 (2017-10-13) |
* Document for »About Section«: AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for AbCellera (Group)
- [1] AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC....
- [2] AbCellera Biologics, Inc.. (11/29/18). "Press Release: AbCellera Collaborates with Autolus on Antibody Discovery Project". Vancouver, BC....
- [3] AbCellera Biologics, Inc.. (5/30/18). "Press Release: AbCellera and Harbour Antibodies Announce Technology Co-Offering Agreement for Next-Generation Fully-Human Antibody Discovery". Vancouver, BC, Rotterdam & Cambridge, MA....
- [4] AbCellera Biologics, Inc.. (9/12/17). "Press Release: AbCellera Launches Antibody Discovery Collaboration with GSK". Vancouver, BC....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top